CADL

Candel Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↑ 8/10
  • Momentum↓ 3/10
Candel Therapeutics sales and earnings growth
CADL Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 68.79%
  • FCF Y/Y↓ -17.58%
Candel Therapeutics gross and profit margin trends
CADL Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 353.60%
Candel Therapeutics net debt vs free cash flow
CADL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -19.8

Candel Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗